Today: 9 April 2026
Subscribe
Browse Category

NASDAQ:RVPH 24 October 2025 - 9 March 2026

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals enacted a 1-for-20 reverse stock split early Monday to boost its share price and avoid a Nasdaq delisting. The company faces a March 27 deadline to meet the $1 minimum bid rule. Reviva is also seeking funding for a new Phase 3 trial of its schizophrenia drug after the FDA requested more data. Analyst Jason Kolbert downgraded the stock, citing unchanged fundamentals.
9 March 2026
·
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
24 December 2025
···
Reviva Pharmaceuticals (RVPH) Stock Today: Price, News, Forecast & Schizophrenia NDA Setup – 10 December 2025

Reviva Pharmaceuticals (RVPH) Stock Today: Price, News, Forecast & Schizophrenia NDA Setup – 10 December 2025

Reviva Pharmaceuticals (RVPH) traded around $0.69 per share mid-session December 10, up 10% on the day but still down 72% over the past year. Market cap stood near $78–80 million. On December 9, call options volume spiked 458% above average as traders speculated on upcoming catalysts. The company’s lead drug, brilaroxazine, recently completed Phase 3 trials in schizophrenia.
10 December 2025
··
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

RVPH shares closed at $0.57 on Oct 24 after a volatile month, swinging between $0.26 and $0.84. The stock surged 28% on Oct 23 following recent Phase 3 trial results for brilaroxazine and news of an upcoming FDA meeting. Reviva raised about $19 million this year to fund its CNS pipeline. Analyst targets average $6.25, implying a potential 1,000% upside.
24 October 2025
···

Stock Market Today

  • Scotiabank Lowers Cargojet (TSE:CJT) Price Target to C$115 Amid Mixed Analyst Ratings
    April 9, 2026, 3:34 PM EDT. Scotiabank cut Cargojet's price target from C$118 to C$115, maintaining an "outperform" rating with a 40.67% upside potential. Other analysts showed varied views: RBC lowered its target to C$143, Canadian Imperial Bank of Commerce raised theirs to C$122, and Stifel Nicolaus boosted theirs to C$120. Cargojet's stock traded down 2.4% at C$81.75, below its 50-day average of C$89.73. The air cargo company reported a net margin of 8.08% and a return on equity of 10.73% last quarter, with expectations of 5.89 earnings per share this year. The market cap stands at C$1.22 billion, with a price-to-earnings ratio of 15.60.

Latest article

Mortgage Rates Today: 30-Year Fixed Falls to 6.37% After Five-Week Climb (Freddie Mac)

Mortgage Rates Today: 30-Year Fixed Falls to 6.37% After Five-Week Climb (Freddie Mac)

9 April 2026
The average 30-year fixed mortgage rate fell to 6.37% from 6.46%, Freddie Mac said Thursday. Purchase mortgage applications rose 1% last week but remained 7% lower than a year ago, according to the Mortgage Bankers Association. Refinance activity dropped 3%. Mortgage News Daily’s index showed the 30-year fixed at 6.38%, with the 10-year Treasury near 4.27%.
Bitcoin Price Today: Why BTC Is Stuck Between Ceasefire Relief and ETF Doubts

Bitcoin Price Today: Why BTC Is Stuck Between Ceasefire Relief and ETF Doubts

9 April 2026
Bitcoin traded near $72,000 Thursday, up 0.3%, after earlier slipping on renewed Middle East tensions. U.S. spot bitcoin ETFs saw $471.4 million in inflows April 6 but $93.9 million in outflows April 8, as Morgan Stanley’s new MSBT fund debuted with $30.6 million. Ether fell 0.9% to $2,210.56. Bitcoin remains 43% below its October 2025 record high.
Silver Price Today Jumps Toward $76 as Dollar Slides and Iran Ceasefire Wobbles

Silver Price Today Jumps Toward $76 as Dollar Slides and Iran Ceasefire Wobbles

9 April 2026
Spot silver jumped 2.9% to $76.24 an ounce Thursday, extending gains after a U.S.-Iran ceasefire and a weaker dollar. Gold rose 1.63% to $4,793.07. Analysts warned the truce remains fragile, with markets watching for March U.S. inflation data due Friday. Oil fell below $100 but tensions persisted in the Middle East.
Gold Price Today: Bullion Jumps as Dollar Slips and Fragile Iran Truce Keeps CPI in Focus

Gold Price Today: Bullion Jumps as Dollar Slips and Fragile Iran Truce Keeps CPI in Focus

9 April 2026
Spot gold rose 1.6% to $4,789.67 an ounce by 1:30 p.m. ET Thursday as the U.S. dollar weakened and Treasury yields slipped. U.S. gold futures settled 0.9% higher at $4,818.00. Traders watched a fragile ceasefire between Washington and Tehran and awaited Friday’s U.S. inflation data. March saw gold’s steepest monthly drop since 2008, according to China’s central bank.
Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

Dow Jones Today: Industrial Average Climbs as Oil Retreats, but Inflation Risk Keeps Wall Street Wary

9 April 2026
The Dow Jones rose 247.66 points to 48,155.97 by midday Thursday, following a surge linked to signs of Middle East de-escalation and Israeli plans for peace talks with Lebanon. Oil prices fell over $4 a barrel after Netanyahu’s remarks, but remain 40% above pre-conflict levels. Amazon climbed 4.3% on strong AI revenue. Traders now see only a 30% chance of a Fed rate cut by year-end, down from 56%.
Go toTop